US 12,213,775 B1
Devices and methods for sleep disorder diagnosis and treatment
Hani Kayyali, Shaker Heights, OH (US); Robert N. Schmidt, Ft. Myers, FL (US); Mohammad Modarres-Zadeh, Tampa, FL (US); and Brian Kolkoski, Leroy, OH (US)
Assigned to Cleveland Medical Devices Inc., Cleveland, OH (US)
Filed by Cleveland Medical Devices Inc., Cleveland, OH (US)
Filed on Nov. 16, 2023, as Appl. No. 18/510,801.
Application 18/510,801 is a continuation of application No. 18/105,277, filed on Feb. 3, 2023, granted, now 11,872,029.
Application 18/105,277 is a continuation of application No. 17/825,266, filed on May 26, 2022, granted, now 11,602,284, issued on Mar. 14, 2023.
Application 17/825,266 is a continuation of application No. 16/057,963, filed on Aug. 8, 2018, granted, now 11,375,921, issued on Jul. 5, 2022.
Application 16/057,963 is a continuation of application No. 13/440,116, filed on Apr. 5, 2012, granted, now 10,076,269, issued on Sep. 18, 2018.
Application 13/440,116 is a continuation of application No. 11/266,899, filed on Nov. 4, 2005, granted, now 8,172,766, issued on May 8, 2012.
This patent is subject to a terminal disclaimer.
Int. Cl. A61B 5/085 (2006.01); A61B 5/00 (2006.01); A61B 5/0205 (2006.01); A61B 5/08 (2006.01); A61M 16/00 (2006.01)
CPC A61B 5/085 (2013.01) [A61B 5/4815 (2013.01); A61B 5/02055 (2013.01); A61M 2016/0027 (2013.01); A61M 2016/0039 (2013.01); A61M 16/0051 (2013.01); A61M 16/0069 (2014.02); A61M 2202/0208 (2013.01); A61M 2205/3553 (2013.01); A61M 2205/3561 (2013.01); A61M 2205/3584 (2013.01); A61M 2205/3592 (2013.01); A61M 2230/04 (2013.01); A61M 2230/10 (2013.01); A61M 2230/14 (2013.01); A61M 2230/202 (2013.01); A61M 2230/205 (2013.01); A61M 2230/60 (2013.01)] 20 Claims
OG exemplary drawing
 
1. A positive airway pressure (PAP) sleep disorder treatment system comprising:
a non-transitory computer readable medium comprising a first software, the first software adapted to be downloaded to a cell phone and executable by a first processor on the cell phone to display to a subject for viewing on the cell phone a treatment efficacy of the subject using a PAP device, the treatment efficacy based in whole or in part on a data based on one or more measure(s) of the treatment efficacy received by the first software, the cell phone comprising at least one first radio frequency wireless transceiver, the first processor, the first software when downloaded, and a display;
the PAP device with an enclosure further comprising:
a blower having an air output within the enclosure,
an airflow sensor being any type of sensor internal to the enclosure of the PAP device adapted for measuring or deriving the respiratory airflow of a subject while using the PAP device and outputting airflow sensor data,
a second processor within the enclosure adapted for receiving the airflow sensor data and for calculating the one or more measures of the treatment efficacy comprising:
i) the data of a severity of the sleep disorder symptoms of the subject,
ii) the data of usage of the PAP device by the subject, and/or
iii) the index based in whole or in part on either i) or ii) or both i) and ii),
a mask or a nasal cannula connected to the enclosure, and
at least one second radio frequency wireless transceiver within the enclosure, the at least one second radio frequency wireless transceiver adapted for transmitting a PAP data based in whole or part on at least one of the one or more measures of treatment efficacy calculated by the second processor; and
a remote internet site, the remote internet site adapted for receiving the PAP data or data based on the at least one of the one or more treatment efficacy measures, related to the subject's treatment and the treatment's efficacy in whole or part, generated by the PAP device and transmitted via the at least one second radio frequency wireless transceiver.